Cellular effects of paclitaxel-loaded iron oxide nanoparticles on breast cancer using different 2D and 3D cell culture models

Stephan Lugert,1,2 Harald Unterweger,1 Marina Mühlberger,1 Christina Janko,1 Sebastian Draack,3 Frank Ludwig,3 Dietmar Eberbeck,4 Christoph Alexiou,1 Ralf P Friedrich1 1Department of Otorhinolaryngology, Head and Neck Surgery, Section of Experimental Oncology and Nanomedicine (SEON), Else...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Lugert S, Unterweger H, Mühlberger M, Janko C, Draack S, Ludwig F, Eberbeck D, Alexiou C, Friedrich RP
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://doaj.org/article/a5a961c54bd64ea8913775af1b0e21d4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a5a961c54bd64ea8913775af1b0e21d4
record_format dspace
spelling oai:doaj.org-article:a5a961c54bd64ea8913775af1b0e21d42021-12-02T09:39:49ZCellular effects of paclitaxel-loaded iron oxide nanoparticles on breast cancer using different 2D and 3D cell culture models1178-2013https://doaj.org/article/a5a961c54bd64ea8913775af1b0e21d42018-12-01T00:00:00Zhttps://www.dovepress.com/cellular-effects-of-paclitaxel-loaded-iron-oxide-nanoparticles-on-brea-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Stephan Lugert,1,2 Harald Unterweger,1 Marina Mühlberger,1 Christina Janko,1 Sebastian Draack,3 Frank Ludwig,3 Dietmar Eberbeck,4 Christoph Alexiou,1 Ralf P Friedrich1 1Department of Otorhinolaryngology, Head and Neck Surgery, Section of Experimental Oncology and Nanomedicine (SEON), Else Kröner-Fresenius-Stiftung-Professorship, Universitätsklinikum Erlangen, Erlangen, Germany; 2Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; 3Institut für Elektrische Messtechnik und Grundlagen der Elektrotechnik, TU Braunschweig, Braunschweig, Germany; 4Physikalisch-Technische Bundesanstalt Braunschweig und Berlin, Berlin, Germany Background: Magnetic drug targeting (MDT) is an effective alternative for common drug applications, which reduces the systemic drug load and maximizes the effect of, eg, chemotherapeutics at the site of interest. After the conjugation of a magnetic carrier to a chemotherapeutic agent, the intra-arterial injection into a tumor-afferent artery in the presence of an external magnetic field ensures the accumulation of the drug within the tumor tissue.Materials and methods: In this study, we used superparamagnetic iron oxide nanoparticles (SPIONs) coated with lauric acid and human serum albumin as carriers for paclitaxel (SPIONLA-HSA-Ptx). To investigate whether this particle system is suitable for a potential treatment of cancer, we investigated its physicochemical properties by dynamic light scattering, ζ potential measurements, isoelectric point titration, infrared spectroscopy, drug release quantification, and magnetic susceptibility measurements. The cytotoxic effects were evaluated using extensive toxicological methods using flow cytometry, IncuCyte® live-cell imaging, and growth experiments on different human breast cancer cell lines in two- and three-dimensional cell cultures.Conclusion: The data showed that next to their high magnetization capability, SPIONLA-HSA-Ptx have similar cytostatic effects on human breast cancer cells as pure paclitaxel, suggesting their usage for future MDT-based cancer therapy. Keywords: superparamagnetic iron oxide nanoparticles, SPIONs, three-dimensional cell culture, toxicity, flow cytometry, magnetic drug targeting Lugert SUnterweger HMühlberger MJanko CDraack SLudwig FEberbeck DAlexiou CFriedrich RPDove Medical Pressarticlesuperparamagnetic iron oxide nanoparticlesSPION3D cell culturetoxicityflow cytometryMagnetic Drug TargetingMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 14, Pp 161-180 (2018)
institution DOAJ
collection DOAJ
language EN
topic superparamagnetic iron oxide nanoparticles
SPION
3D cell culture
toxicity
flow cytometry
Magnetic Drug Targeting
Medicine (General)
R5-920
spellingShingle superparamagnetic iron oxide nanoparticles
SPION
3D cell culture
toxicity
flow cytometry
Magnetic Drug Targeting
Medicine (General)
R5-920
Lugert S
Unterweger H
Mühlberger M
Janko C
Draack S
Ludwig F
Eberbeck D
Alexiou C
Friedrich RP
Cellular effects of paclitaxel-loaded iron oxide nanoparticles on breast cancer using different 2D and 3D cell culture models
description Stephan Lugert,1,2 Harald Unterweger,1 Marina Mühlberger,1 Christina Janko,1 Sebastian Draack,3 Frank Ludwig,3 Dietmar Eberbeck,4 Christoph Alexiou,1 Ralf P Friedrich1 1Department of Otorhinolaryngology, Head and Neck Surgery, Section of Experimental Oncology and Nanomedicine (SEON), Else Kröner-Fresenius-Stiftung-Professorship, Universitätsklinikum Erlangen, Erlangen, Germany; 2Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; 3Institut für Elektrische Messtechnik und Grundlagen der Elektrotechnik, TU Braunschweig, Braunschweig, Germany; 4Physikalisch-Technische Bundesanstalt Braunschweig und Berlin, Berlin, Germany Background: Magnetic drug targeting (MDT) is an effective alternative for common drug applications, which reduces the systemic drug load and maximizes the effect of, eg, chemotherapeutics at the site of interest. After the conjugation of a magnetic carrier to a chemotherapeutic agent, the intra-arterial injection into a tumor-afferent artery in the presence of an external magnetic field ensures the accumulation of the drug within the tumor tissue.Materials and methods: In this study, we used superparamagnetic iron oxide nanoparticles (SPIONs) coated with lauric acid and human serum albumin as carriers for paclitaxel (SPIONLA-HSA-Ptx). To investigate whether this particle system is suitable for a potential treatment of cancer, we investigated its physicochemical properties by dynamic light scattering, ζ potential measurements, isoelectric point titration, infrared spectroscopy, drug release quantification, and magnetic susceptibility measurements. The cytotoxic effects were evaluated using extensive toxicological methods using flow cytometry, IncuCyte® live-cell imaging, and growth experiments on different human breast cancer cell lines in two- and three-dimensional cell cultures.Conclusion: The data showed that next to their high magnetization capability, SPIONLA-HSA-Ptx have similar cytostatic effects on human breast cancer cells as pure paclitaxel, suggesting their usage for future MDT-based cancer therapy. Keywords: superparamagnetic iron oxide nanoparticles, SPIONs, three-dimensional cell culture, toxicity, flow cytometry, magnetic drug targeting 
format article
author Lugert S
Unterweger H
Mühlberger M
Janko C
Draack S
Ludwig F
Eberbeck D
Alexiou C
Friedrich RP
author_facet Lugert S
Unterweger H
Mühlberger M
Janko C
Draack S
Ludwig F
Eberbeck D
Alexiou C
Friedrich RP
author_sort Lugert S
title Cellular effects of paclitaxel-loaded iron oxide nanoparticles on breast cancer using different 2D and 3D cell culture models
title_short Cellular effects of paclitaxel-loaded iron oxide nanoparticles on breast cancer using different 2D and 3D cell culture models
title_full Cellular effects of paclitaxel-loaded iron oxide nanoparticles on breast cancer using different 2D and 3D cell culture models
title_fullStr Cellular effects of paclitaxel-loaded iron oxide nanoparticles on breast cancer using different 2D and 3D cell culture models
title_full_unstemmed Cellular effects of paclitaxel-loaded iron oxide nanoparticles on breast cancer using different 2D and 3D cell culture models
title_sort cellular effects of paclitaxel-loaded iron oxide nanoparticles on breast cancer using different 2d and 3d cell culture models
publisher Dove Medical Press
publishDate 2018
url https://doaj.org/article/a5a961c54bd64ea8913775af1b0e21d4
work_keys_str_mv AT lugerts cellulareffectsofpaclitaxelloadedironoxidenanoparticlesonbreastcancerusingdifferent2dand3dcellculturemodels
AT unterwegerh cellulareffectsofpaclitaxelloadedironoxidenanoparticlesonbreastcancerusingdifferent2dand3dcellculturemodels
AT muhlbergerm cellulareffectsofpaclitaxelloadedironoxidenanoparticlesonbreastcancerusingdifferent2dand3dcellculturemodels
AT jankoc cellulareffectsofpaclitaxelloadedironoxidenanoparticlesonbreastcancerusingdifferent2dand3dcellculturemodels
AT draacks cellulareffectsofpaclitaxelloadedironoxidenanoparticlesonbreastcancerusingdifferent2dand3dcellculturemodels
AT ludwigf cellulareffectsofpaclitaxelloadedironoxidenanoparticlesonbreastcancerusingdifferent2dand3dcellculturemodels
AT eberbeckd cellulareffectsofpaclitaxelloadedironoxidenanoparticlesonbreastcancerusingdifferent2dand3dcellculturemodels
AT alexiouc cellulareffectsofpaclitaxelloadedironoxidenanoparticlesonbreastcancerusingdifferent2dand3dcellculturemodels
AT friedrichrp cellulareffectsofpaclitaxelloadedironoxidenanoparticlesonbreastcancerusingdifferent2dand3dcellculturemodels
_version_ 1718398080690159616